Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials
Published: | Updated:
Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.
